TY - JOUR
T1 - Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on short-term postoperative outcomes
T2 - a nationwide population-based study
AU - Dutch Hepato Biliary Audit Group
AU - Elfrink, Arthur K E
AU - Nieuwenhuizen, Sanne
AU - van den Tol, M Petrousjka
AU - Burgmans, Mark C
AU - Prevoo, Warner
AU - Coolsen, Marielle M E
AU - van den Boezem, Peter B
AU - van Delden, Otto M
AU - Hagendoorn, Jeroen
AU - Patijn, Gijs A
AU - Leclercq, Wouter K G
AU - Liem, Mike S L
AU - Rijken, Arjen M
AU - Verhoef, Cornelis
AU - Kuhlmann, Koert F D
AU - Ruiter, Simeon J S
AU - Grünhagen, Dirk J
AU - Klaase, Joost M
AU - Kok, Niels F M
AU - Meijerink, Martijn R
AU - Swijnenburg, Rutger-Jan
AU - Consten, Esther
N1 - Copyright © 2020 University Medical Center Groningen. Published by Elsevier Ltd.. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - Background: Combining resection and thermal ablation can improve short-term postoperative outcomes in patients with colorectal liver metastases (CRLM). This study assessed nationwide hospital variation and short-term postoperative outcomes after combined resection and ablation.Methods: In this population-based study, all CRLM patients who underwent resection in the Netherlands between 2014 and 2018 were included. After propensity score matching for age, ASA-score, Charlson-score, diameter of largest CRLM, number of CRLM and earlier resection, postoperative outcomes were compared. Postoperative complicated course (PCC) was defined as discharge after 14 days or a major complication or death within 30 days of surgery.Results: Of 4639 included patients, 3697 (80%) underwent resection and 942 (20%) resection and ablation. Unadjusted percentage of patients who underwent resection and ablation per hospital ranged between 4 and 44%. Hospital variation persisted after case-mix correction. After matching, 734 patients remained in each group. Hospital stay (median 6 vs. 7 days, p = 0.011), PCC (11% vs. 14.7%, p = 0.043) and 30-day mortality (0.7% vs. 2.3%, p = 0.018) were lower in the resection and ablation group. Differences faded in multivariable logistic regression due to inclusion of major hepatectomy.Conclusion: Significant hospital variation was observed in the Netherlands. Short-term postoperative outcomes were better after combined resection and ablation, attributed to avoiding complications associated with major hepatectomy.
AB - Background: Combining resection and thermal ablation can improve short-term postoperative outcomes in patients with colorectal liver metastases (CRLM). This study assessed nationwide hospital variation and short-term postoperative outcomes after combined resection and ablation.Methods: In this population-based study, all CRLM patients who underwent resection in the Netherlands between 2014 and 2018 were included. After propensity score matching for age, ASA-score, Charlson-score, diameter of largest CRLM, number of CRLM and earlier resection, postoperative outcomes were compared. Postoperative complicated course (PCC) was defined as discharge after 14 days or a major complication or death within 30 days of surgery.Results: Of 4639 included patients, 3697 (80%) underwent resection and 942 (20%) resection and ablation. Unadjusted percentage of patients who underwent resection and ablation per hospital ranged between 4 and 44%. Hospital variation persisted after case-mix correction. After matching, 734 patients remained in each group. Hospital stay (median 6 vs. 7 days, p = 0.011), PCC (11% vs. 14.7%, p = 0.043) and 30-day mortality (0.7% vs. 2.3%, p = 0.018) were lower in the resection and ablation group. Differences faded in multivariable logistic regression due to inclusion of major hepatectomy.Conclusion: Significant hospital variation was observed in the Netherlands. Short-term postoperative outcomes were better after combined resection and ablation, attributed to avoiding complications associated with major hepatectomy.
KW - INTRAOPERATIVE RADIOFREQUENCY ABLATION
KW - PARENCHYMAL SPARING SURGERY
KW - MICROWAVE ABLATION
KW - HEPATIC RESECTION
KW - COMPLICATIONS
KW - CANCER
U2 - 10.1016/j.hpb.2020.10.003
DO - 10.1016/j.hpb.2020.10.003
M3 - Article
C2 - 33218949
SN - 1365-182X
VL - 23
SP - 827
EP - 839
JO - HPB
JF - HPB
IS - 6
ER -